My crohns

Hey all, how are we all doing?? Sorry i havent been posting blogs for a while now, sort of been busy buuuuuut i am back and to give you some info on another new biosimilar infliximab drug that i have been trialing called Remsima and to give you an update on where i am at the moment. Remsima Remsima (Rem-see-ma) is another biosimilar from the Anti-tnf drug called Infliximab, its a cheaper solution than Infliximab while doing the same job. It is taken the same way as Infliximab and Inflectra via intravenous drip into the arm and helped pushed through using a machine, again same as the Infliximab and Inflectra, this takes roughly 2 hours depending on the patient, at the moment for me it takes 1 hour to put through my body and then a further hour just to see if anything bad happens. The amount that a person takes in one session is depending on the persons weight, i think its 5ml to 1kg, next time i got one is on 1 September 2017, i will double check if i got the measurments righ...

Hey all my lovely readers, hope everything is fine with you guys. This time i will be talking about the MAP vaccine and where they are at it and then do my usual update. So the MAP vaccine will target the MAP bug (Mycobacterium avium paratuberculosis) which is found in animals and is passed into the food chain. Doctors have already linked this bug to be the majority of the reason why people have crohns but while the UK governments advisory committee on the Microbiological safety of food insists that this transmission from animals to humans cannot be proven to give someone crohns, despite the bug being heavily noted in milk. How does this vaccine help cure someone with Crohns? Well the vaccine will stimulate the patients immune system into targeting the bug and clear it for the system, even though this is good news a survey was done a while ago stating that 8/10 people with crohns showed that they have this MAP bug in their system, from my view on this that it is not a cure for al...